V024-2852 Screening compound: 1-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-3-ethyl-1-[2-(morpholin-4-yl)ethyl]thiourea

V024-2852 Screening compound: 1-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-3-ethyl-1-[2-(morpholin-4-yl)ethyl]thiourea
V024-2852 Screening compound: 1-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-3-ethyl-1-[2-(morpholin-4-yl)ethyl]thiourea alternative view

Chemical Structure Depiction of ChemDiv screening compound V024-2852
1-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-3-ethyl-1-[2-(morpholin-4-yl)ethyl]thiourea

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V024-2852

Molecular Formula

C27H35N5O3S2 (C27 H35 N5 O3 S2)

Compound Name

1-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-3-ethyl-1-[2-(morpholin-4-yl)ethyl]thiourea

IUPAC name

1-[(1-benzyl-2-phenylmethanesulfonyl-1H-imidazol-5-yl)methyl]-3-ethyl-1-[2-(morpholin-4-yl)ethyl]thiourea

SMILES

CCNC(N(CCN1CCOCC1)Cc(n1Cc2ccccc2)cnc1S(Cc1ccccc1)(=O)=O)=S

InChI

InChI=1S/C27H35N5O3S2/c1-2-28-26(36)31(14-13-30-15-17-35-18-16-30)21-25-19-29-27(32(25)20-23-9-5-3-6-10-23)37(33,34)22-24-11-7-4-8-12-24/h3-12,19H,2,13-18,20-22H2,1H3,(H,28,36)

InChI Key

RSPZTDKIEDLFIO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19978348

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

541.74

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.882

Distribution Coefficient, logD

1.851

Water Solubility, LogSw

-3.06

Polar Surface Area

63.930

Acid Dissociation Constant (pKa)

17.87

Base Dissociation Constant (pKb)

8.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.70

V024-2852 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V024-2852 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V024-2852?
Check Price and Availability of V024-2852, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V024-2852 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V024-2852
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V024-2852
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V024-2852 available by request